Guo Chunguang, Liu Qian, Dai Min
Department of Abdominal Surgery, Cancer Hospital Institute, Chinese Academy of Medical Science, Beijing 100021, China.
Email:
Zhonghua Yu Fang Yi Xue Za Zhi. 2015 May;49(5):377-80.
Colorectal cancer (CRC) is the fourth most common cause of cancer death in China and the incidence has been increasing during the decades. It is reported to take decades for adenoma to transform to carcinoma, which is known as the main CRC pre-cancer lesion. It is important to carry out mass screening in the average risk populations to find the pre-cancer lesion and early cancer, which was the key approach to improve CRC survival. Fecal occult blood test and flexible sigmoidoscopy are the two CRC screening methods, which have been shown to reduce CRC mortality. It still needs to be confirmed in random clinical trials that the value of colonoscopy in CRC screening. In China, the most CRC screening experience was drawn from the works in Zhejiang province in 1970s. Consequently, the Chinese CRC treatment and guideline was founded to provide standard for the CRC screening project.
结直肠癌(CRC)是中国癌症死亡的第四大常见原因,且在过去几十年中发病率一直在上升。据报道,腺瘤转变为癌需要数十年时间,腺瘤是已知的主要结直肠癌癌前病变。对平均风险人群进行大规模筛查以发现癌前病变和早期癌症非常重要,这是提高结直肠癌生存率的关键方法。粪便潜血试验和乙状结肠镜检查是两种结直肠癌筛查方法,已被证明可降低结直肠癌死亡率。结肠镜检查在结直肠癌筛查中的价值仍需随机临床试验来证实。在中国,大多数结直肠癌筛查经验来自20世纪70年代浙江省的工作。因此,制定了中国结直肠癌治疗和指南,为结直肠癌筛查项目提供标准。